FEASIBILITY STUDY FOR IDENTIFYING ANTI CAPSULAR ANTIBODY PROTECTION AGAINST INVASIVE GROUP B STREPTOCOCCUS (GBS) DISEASE IN NEWBORNS OF 0-6 DAYS AGE (EARLY ONSET DISEASE [EOD]) AS WELL AS AMONG INFANTS OF 7-90 DAYS AGE (LATE ONSET DISEASE [LOD]):